New Bluesight for Controlled Substances Feature: Investigation Portfolios
New Bluesight for Controlled Substances Feature: Investigation Portfolios
We are excited to announce the launch of our newest feature for the Bluesight for …
Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios
Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 …
Webinar: The Diversion Gap and What to Do About It
Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what …
HIStalk Interviews Kit Check CEO Kevin MacDonald
Kit Check CEO Kevin MacDonald was recently interviewed by HISTalk and shared some thoughts on…
Identifying Diversion by Location — A Practical Application of Machine Learning
In the day-to-day battle against drug diversion, most solutions look at the data to find …
Now What? Responding to Diversion Events with Speed and Impact
As the national conversation around opioid abuse continues to grow, hospitals grappling with citations, fines…
Increasing scrutiny for hospital pharmacies over management and use of controlled substance inventory
As the opioid epidemic continues to make headlines, hospitals are facing increasing pressure to detect…
2 of 2